GPX2 and neoplasm: In a xenograft model of MKN45 cells, compared with the control group, we observed that knockdown of GPX2 inhibited tumor growth and enhanced cisplatin drug sensitivity, further confirming the synergistic promotion of GPX2 knockdown on cisplatin-induced apoptosis (Fig. 8G–J).